• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    MPO's 2023 Medtech Supply Chain Survey

    Exceeding Medical Device Extrusion Expectations

    Medical Device Micromolders Discuss the 'Minor Details'

    Superior Subtractive Solutions for Machining Medtech

    Assembly & Automation Experts Share Thoughts on Medtech Trends
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Steven Goetz Joins Motif Neurotech as Chief Technology Officer

    ZAP Surgical Wins Two More IP Battles with Elekta

    3D Systems Partners with Klarity to Expand Distribution of VSP Bolus Solution

    Zeus Introduces Absorv XSE Oriented Tubing

    Laminate's VasQ Nabs De Novo Nod to Create AVFs for Dialysis Access
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    MPO's 2023 Medtech Supply Chain Survey

    Exceeding Medical Device Extrusion Expectations

    Medical Device Micromolders Discuss the 'Minor Details'

    Superior Subtractive Solutions for Machining Medtech

    Assembly & Automation Experts Share Thoughts on Medtech Trends
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Back to School for Medical Device Cybersecurity Training

    Driving Clinical Trial Excellence to Help Study Teams Run a Faster Relay Race

    Medtech’s Supply Chain: From Disruption to Opportunity

    Are Medtech’s Mega-Deals Gone For Good?

    Will a Skilling Gap Hinder Organizational Readiness for Medtech’s New Age of AI?
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Halkey-Roberts Corporation

    LEMO USA Inc.

    NDH Medical Inc.

    Arthur G. Russell Co. Inc., The

    JBC Technologies
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How Wearables Are Changing the Way We Collect Real-World Data in Clinical Trials

    Could Medtech Ever Stop a Hospital Killer in Their Tracks?

    A One-Stop-Shop, Turnkey Solution Is Paramount for Success

    How Additive and Subtractive Manufacturing Are Revolutionizing the Medical Device Industry

    Medical Device Commercialization: It’s What, Not When, to Transfer to Manufacturing
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Halkey-Roberts Corporation

    LEMO USA Inc.

    NDH Medical Inc.

    Arthur G. Russell Co. Inc., The

    JBC Technologies
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    The Advantages of Bioburden Screening for Sterilization Validation

    Bioburden can be introduced at several stages throughout the manufacturing process.

    The Advantages of Bioburden Screening for Sterilization Validation
    Shelley Zimmerman and Cathy Leckwart, WuXi AppTec06.01.22
    The use of ionizing radiation (i.e., X-rays, gamma rays, or electron beam) to sterilize medical devices has significantly increased in recent years. About 12 million cubic meters of medical devices are irradiated every year, and more than 40 percent of that total is sterilized via gamma irradiation. Irradiation can be a highly efficient way to kill microorganisms and is performed on devices that have already been packaged.

    Radiation sterilization studies are performed to substantiate the radiation dose to be used for sterilization of a medical device to a specific Sterility Assurance Level (SAL). The SAL is measured in 10-n, with 10-3 or 10-6 being the most common SAL levels. A 10-3 SAL means there is a 1 in 1,000 probability, after sterilization, of a single viable microorganism occurring on a product (i.e., non-sterile). A 10-6 would mean a one in 1,000,000 probability that a device is non-sterile. Regulators will expect to see manufacturers’ sterilization validation data that confirms their labeling claims.

    Bioburden can be introduced at several stages throughout the manufacturing process—from raw materials, the workforce, or the manufacturing environment—so routine testing is essential. Understanding the bioburden level is one of the most critical steps in sterilization validation. Once scientists determine bioburden level through microbial identification and characterization, the dose level is substantiated and becomes the basis for dose audits.

    The Regulatory Landscape for Bioburden Screening

    Radiation sterilization studies are based on sterilization guidelines specified in ISO 11137-2. According to ISO guidance, dose audit procedures test the sterility of products that have received doses of radiation lower than the terminal sterilization dose. In short, a validation study helps evaluate the effectiveness of the sterilization dose that was calculated to eliminate bioburden.

    ISO 11137-2 includes specific requirements regarding the number of samples required for a radiation validation and dose audit testing. The testing lab will comply with the necessary instructions per the standard.

    Selecting the Right Product for Studies

    Choosing the right product as a representative in radiation sterilization studies is key to testing success. Guidance documents provide direction on the assessment needed to select a representative product for dose substantiation and verification testing (sterilization dose audits).

    As the ISO standard states: “Consideration shall include all product-related variables that affect bioburden, including, but not limited to: a) nature and sources of raw materials, including the effect, if any, of raw materials that might be sourced from more than one location; b) components; c) product design and size; d) manufacturing processes; e) manufacturing equipment; f) manufacturing environment; g) manufacturing location.”

    When testing sterilization dosage for a product family, device manufacturers are often inclined to select the “worst-case” products in terms of size and complexity. At first glance, this may seem logical and even intuitive. But your lab testing partner may recommend a more effective testing strategy.

    Sterilization dose audits typically occur every quarter and must be documented. By limiting validation test samples to only the worst-case products, manufacturers risk running out of suitable representatives. There are advantages to bioburden screening that manufacturers may not realize. 

    Advantages of Bioburden Screening

    Bioburden screening can be an effective assessment tool to ensure the most suitable representative product is selected for radiation sterilization studies and dose audits, which manufacturers do not always understand. Some manufacturers may consider it an additional expense without clear benefits. Accurately understanding bioburden minimizes patient risk and is paramount for regulatory success.

    When bioburden screening is performed as a part of the sterilization validation, the screening is being used to assess the microbiological equivalence or difference of family members to select either a “master” or “equivalent” product. If a product family member exhibits bioburden that is significantly higher than other family members, it is considered a master product. The master product would be the member chosen to represent the family for dose substantiation and verification dose experiments. However, submitting the master product for validation studies can lead to availability and cost challenges previously mentioned. But, when all family members exhibit microbiological equivalency, they are considered an equivalent product. And equivalent products selected to represent the family can be chosen at random or according to a rotating schedule, freeing up valuable samples for quarterly dose audits and keeping timelines and budgets intact.

    Consult With a Lab Testing Partner

    Understanding the complexities and nuances of bioburden screening can significantly reduce time and costs during medical device testing. Strong connections and open dialogue with experienced laboratory testing partners can make a big difference. Lab partners often have access to industry norms and testing strategies that manufacturers may not have in-house. This leads to accurate and reproducible results and, ultimately, greater patient safety.

    In addition, experienced testing partners will be able to demonstrate regulatory compliance and success. They should be able to supply references to confirm a track record of setting realistic milestones and achieving project goals. An oft-overlooked advantage to establishing a strong relationship with a lab testing partner is data accessibility. Lab partners will store relevant data and in-process test results to ensure manufacturers have the answers they need for the next dose audit or regulatory submission. Keeping these data in-house can cause organizational confusion and unnecessary delays.

    A Final Word

    The benefits of achieving product equivalency during sterilization validation can be misunderstood or overlooked, but it can help manufacturers curb costs and alleviate product availability issues. Collaborating with a proven laboratory testing partner can help manufacturers navigate the regulatory landscape and help companies achieve regulatory compliance. 


    Shelley Zimmerman is a manager of Laboratory Services with WuXi AppTec. Shelley specializes in medical device testing for radiation sterilization studies and dose audits.

    Cathy Leckwart is a senior technical specialist at WuXi AppTec. Cathy specializes in sterilization management, microbiology testing, and quality assurance.
    Related Searches
    • Packaging & Sterilization
    Related Knowledge Center
    • Packaging & Sterilization
      Loading, Please Wait..

      Trending
      • Cardiosense Begins SEISMIC-HF I Heart Failure Trial
      • Danaher Names New Environmental And Applied Solutions Company Veralto
      • Exo Introduces The Exo Iris To Market
      • A New Approach To Post-Market Surveillance
      • Varian Buys Aspekt Solutions To Bolster Advanced Oncology Biz
      Breaking News
      • ZOLL Expands Temperature Management Portfolio to Include IQool System
      • Steven Goetz Joins Motif Neurotech as Chief Technology Officer
      • ZAP Surgical Wins Two More IP Battles with Elekta
      • 3D Systems Partners with Klarity to Expand Distribution of VSP Bolus Solution
      • Zeus Introduces Absorv XSE Oriented Tubing
      View Breaking News >
      CURRENT ISSUE

      October 2023

      • MPO's 2023 Medtech Supply Chain Survey
      • Exceeding Medical Device Extrusion Expectations
      • Medical Device Micromolders Discuss the 'Minor Details'
      • View More >

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      PLT Health Solutions Granted Claims for Botanical Ingredient in Canada
      CRN Files Petition with FTC For Clarity on Health Products Compliance Guidance
      Vitafoods Europe Relocates to Barcelona Starting 2025
      Coatings World

      Latest Breaking News From Coatings World

      Hugh Grant to Retire from PPG Board of Directors
      BASF Recognizes Hard Work with Five Prestigious Awards at SEMA
      Arkema Will Decarbonize Acrylics Production at its Carling, France Site
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      Steven Goetz Joins Motif Neurotech as Chief Technology Officer
      ZAP Surgical Wins Two More IP Battles with Elekta
      3D Systems Partners with Klarity to Expand Distribution of VSP Bolus Solution
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Sartorius, SPARTA Biodiscovery Partner on Nanoparticle Analysis Platform
      Ono, Admid Partner on Novel Antibody Drugs in Oncology
      Theradaptive Awarded DOD Clinical Trial Award of up to $7.4M
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      Taramar Unveils Skincare Solution Powered by Kelp
      NYX Professional Makeup Partners with the New York Liberty
      BASF and StitchCrew Introduce Educational Bootcamp for Indigenous Beauty Brands
      Happi

      Latest Breaking News From Happi

      Black Girl Ventures Foundation, Rare Beauty Brands and JCPenney Reveal 2023 National Competition Finalists
      Catch Partners with Rare Beauty, Introduces First Mobile App
      Haircolor Company oVertone and Franzia Wines Create Limited Edition Hair Conditioners
      Ink World

      Latest Breaking News From Ink World

      Arkema Will Decarbonize Acrylics Production at Carling, France Site
      Micro Powders Showcases New Natural, PTFE Alternative Additives at 2023 WCS
      Roland DG Direct-To-Film Printer Ink, Powder Receive ECO PASSPORT Certification
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      INX brings inkjet and sustainable packaging to PRINTING United Expo
      Schreiner MediPharm introduces Freeze-Light-Protect syringe label
      Kodak launches PRINERGY 10.0
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Ed Thomas Receives INDA Lifetime Technical Service Award
      ExxonMobil Works with JL Goor to Help Drive Growth in Ireland and U.K. Healthcare Sector
      Lee C. Stewart Resigns from Glatfelter Board
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      FDA Clears 4WEB Medical's New Integrated Cervical Plate
      CTL Amedica Granted ECAT Approval from Defense Logistics Agency
      Intech Acquires Lenkbar LLC
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Emerson Ventures Invests in First Resonance
      Nearly Six in 10 Warehouse Leaders Plan to Deploy RFID by 2028: Zebra
      Wiliot to Show Enhanced Version of Wiliot Cloud, IoT Pixels, at MWC Las Vegas 2023

      Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login